Search

You searched for "AMD"

1559 results found

Macular atrophy with aflibercept

1 October 2018 | | EYE - Vitreo-Retinal
The authors of this paper set out to investigate the prevalence of macular atrophy in treatment-naive patients with neovascular AMD undergoing aflibercept monotherapy (three monthly loading injections followed by subsequent treatment every two months). Case notes over a three year...
Seminars in Ophthalmology journal cover image

The effects of anti-VEGF therapy for NvAMD on retinal vasculature

4 August 2021 | | EYE - Vitreo-Retinal | aflibercept, foveal avascular zone, neovascular age-related macular degeneration, ranibizumab, retinal vessel density
This retrospective consecutive case series examined 54 eyes of 54 treatment-naïve neovascular age-related macular degeneration (N-AMD) patients. Thirty-three eyes received intravitreal aflibercept injections, and 21 eyes received intravitreal ranibizumab injections with unaffected fellow eyes (54 eyes) as controls. All image...
Journal of Neuro-Ophthalmology cover image.

Exploring the potential of neurodegenerative disease screening within age-related eye disease research

3 August 2023 | | EYE - Neuro-ophthalmology
The authors recruited healthy controls aged between 60 and 75-years-old, previously enrolled into a registry as patients following cataract surgery without age-related macular degeneration (AMD). Exclusion criteria included dense cataract, retinal disease, ocular inflammatory disease, moderate glaucoma, optic neuropathy, cancer,...

Advances and developments in medical retina

1 February 2019 | | EYE - Vitreo-Retinal, EYE - General
The author provides an update on late breaking clinical trial results in neovascular age-related macular degeneration (nAMD) and presentations on diabetes management from the American Academy of Ophthalmology Retina Subspecialty Day, held during the Academy’s annual meeting in Chicago, October...

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

1 February 2015 | | EYE - Vitreo-Retinal
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...

Eye Capacity: clinical need should drive ophthalmic service provision

1 February 2014 |
Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...

Mayor opens new community eye clinic for Lancashire

24 October 2024 | industry, new hospitals, UK, England, AMD, Practice Plus
To further support eye-health for people in the Lancashire region, a new permanent eye care facility has opened in the heart of Bamber Bridge, just three miles from Preston. Opened yesterday by the Mayor and Mayoress of South Ribble Borough...

Glaucoma and cataract CPD sessions for optometrists and dispensing opticians at 100% Optical

14 February 2025 | ISP, independent, industry, 100%, meetings, events, glaucoma, cataract, CPD, training, education
The importance of ophthalmology and optometry working together to transform care for patients with conditions such as cataracts and glaucoma will come under the spotlight at 100% Optical. NHS ophthalmology provider Newmedica is hosting a series of continuing professional development...

Telemedicine strategies in ophthalmology: harnessing established and emerging technologies for lasting solutions

7 December 2020 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - Oculoplastic, EYE - General
The author considers recent progress and shares insights from leading practitioners in telemedicine applications and digital technology strategies. Amidst COVID-19 and combined mitigation and suppression measures, hospitals and clinics have responded rapidly to strengthen telemedicine strategies and virtual healthcare services...

In conversation with Robert MacLaren

2 December 2019 | EYE - Vitreo-Retinal, EYE - General
Professor Robert MacLaren gave the Keeler Lecture at the Royal College of Ophthalmologists Annual Meeting in May 2019 on gene therapy for retinitis pigmentosa. We caught up with him afterwards to find out more. What are the key messages of...

Possible COVID-19 related maculopathy

5 April 2022 | | EYE - Imaging, EYE - Vitreo-Retinal, EYE - Neuro-ophthalmology
COVID-19 is being investigated as a potential cause for various ocular diseases, with growing evidence of related retinal vascular changes, that vary from isolated cotton wool spots and retinal haemorrhages to retinal vascular occlusions [1.2]. COVID-related macular affection has also...

3rd Annual Retinal Imaging Biomarkers & Endpoints Summit

27 May 2025 -29 May 2025
Accelerate Your Ophthalmic Development with Deep Learning Systems & Sophisticated AI Imaging TechnologiesWith state-of-the-art AI-assisted technology making retinal imaging 100 times faster, the rapid advancement of technology in ophthalmology, coupled with the strong unmet need for more drugs for retinal...